LGSPMLJun 30, 2020

Subject-Aware Contrastive Learning for Biosignals

arXiv:2007.04871v1128 citations
AI Analysis

This work addresses challenges in biosignal analysis for medical or research applications, but it is incremental as it builds on existing contrastive learning approaches with domain-specific adaptations.

The paper tackled the problem of noisy labels and limited subjects in biosignal datasets like EEG and ECG by proposing a self-supervised contrastive learning method with subject-aware techniques, resulting in competitive classification performance compared to fully supervised methods and improved representation quality through subject-invariance.

Datasets for biosignals, such as electroencephalogram (EEG) and electrocardiogram (ECG), often have noisy labels and have limited number of subjects (<100). To handle these challenges, we propose a self-supervised approach based on contrastive learning to model biosignals with a reduced reliance on labeled data and with fewer subjects. In this regime of limited labels and subjects, intersubject variability negatively impacts model performance. Thus, we introduce subject-aware learning through (1) a subject-specific contrastive loss, and (2) an adversarial training to promote subject-invariance during the self-supervised learning. We also develop a number of time-series data augmentation techniques to be used with the contrastive loss for biosignals. Our method is evaluated on publicly available datasets of two different biosignals with different tasks: EEG decoding and ECG anomaly detection. The embeddings learned using self-supervision yield competitive classification results compared to entirely supervised methods. We show that subject-invariance improves representation quality for these tasks, and observe that subject-specific loss increases performance when fine-tuning with supervised labels.

Code Implementations1 repo
Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes